Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2024-10-04 11:56 Tx date 2024-10-02 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,474
+3,000 vol $2.16 each |
76,557 | |
Filed 2024-10-04 11:55 Tx date 2024-10-02 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,172
+1,000 vol $2.17 each |
73,557 | |
Filed 2024-10-04 11:55 Tx date 2024-10-02 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$645.00
+300 vol $2.15 each |
72,557 | |
Filed 2024-09-17 17:28 Tx date 2024-09-16 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$719.01
+300 vol $2.40 each |
72,257 | |
Filed 2024-09-03 11:33 Tx date 2024-08-28 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,590
+1,000 vol $1.59 each |
71,957 | |
Filed 2024-08-12 11:35 Tx date 2024-08-09 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,317
+1,000 vol $2.32 each |
70,957 | |
Filed 2024-08-12 11:35 Tx date 2024-08-07 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,264
+1,000 vol $2.26 each |
69,957 | |
Filed 2024-07-08 13:57 Tx date 2024-07-05 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,462
+1,000 vol $2.46 each |
68,957 | |
Filed 2024-03-10 23:15 Tx date 2024-03-04 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+2,222 vol |
10,801 | |
Filed 2024-03-10 23:11 Tx date 2024-03-04 |
$XRTX
XORTX Therapeutics Inc. |
May, Charlotte Mary-Anne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+3,333 vol |
7,920 | |
Filed 2024-03-10 23:09 Tx date 2024-03-04 |
$XRTX
XORTX Therapeutics Inc. |
Fairbairn, James Neville
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+3,333 vol |
5,699 | |
Filed 2024-03-10 23:07 Tx date 2024-03-04 |
$XRTX
XORTX Therapeutics Inc. |
Pratt, Raymond
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+2,222 vol |
8,888 | |
Filed 2024-03-10 23:05 Tx date 2024-03-04 |
$XRTX
XORTX Therapeutics Inc. |
Haworth, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+3,333 vol |
9,032 | |
Filed 2024-03-10 23:04 Tx date 2024-03-04 |
$XRTX
XORTX Therapeutics Inc. |
Farley, William James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+2,222 vol |
9,443 | |
Filed 2024-03-10 23:01 Tx date 2024-03-04 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+6,666 vol |
24,155 | |
Filed 2024-03-08 17:24 Tx date 2024-03-08 |
$XRTX
XORTX Therapeutics Inc. |
Giovinazzo, Anthony J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,091
+1,525 vol $4.65 each |
9,625 | |
Filed 2024-03-07 15:17 Tx date 2024-03-04 |
$XRTX
XORTX Therapeutics Inc. |
Giovinazzo, Anthony J.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$12,699
+2,822 vol $4.50 each |
19,488 | |
Filed 2024-02-20 23:12 Tx date 2024-02-15 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
+10,000 vol |
10,946 | |
Filed 2024-02-20 23:10 Tx date 2024-02-15 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$30,000
+10,000 vol $3.00 each |
67,957 | |
Filed 2024-01-02 12:58 Tx date 2023-11-10 |
$XRTX
XORTX Therapeutics Inc. |
Giovinazzo, Anthony J.
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-133,334 vol |
16,666 | |
Filed 2023-12-28 15:26 Tx date 2023-12-27 |
$XRTX
XORTX Therapeutics Inc. |
Giovinazzo, Anthony J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,737
+600 vol $2.90 each |
8,100 | |
Filed 2023-12-15 11:24 Tx date 2023-12-13 |
$XRTX
XORTX Therapeutics Inc. |
Giovinazzo, Anthony J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$25,665
+7,500 vol $3.42 each |
7,500 | |
Filed 2023-12-15 11:21 Tx date 2022-06-03 |
$XRTX
XORTX Therapeutics Inc. |
Giovinazzo, Anthony J.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-12-14 23:19 Tx date 2023-11-10 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-7,571 vol |
946 | |
Filed 2023-12-14 22:58 Tx date 2023-11-10 |
$XRTX
XORTX Therapeutics Inc. |
Fairbairn, James Neville
5 - Senior Officer of Issuer
Holder: 1282803 Ontario Inc. (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-42,160 vol |
5,270 | |
Filed 2023-12-14 22:57 Tx date 2023-11-10 |
$XRTX
XORTX Therapeutics Inc. |
Fairbairn, James Neville
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-13,408 vol |
1,676 | |
Filed 2023-12-14 22:55 Tx date 2023-11-10 |
$XRTX
XORTX Therapeutics Inc. |
Fairbairn, James Neville
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-18,928 vol |
2,366 | |
Filed 2023-12-14 22:53 Tx date 2023-11-05 |
$XRTX
XORTX Therapeutics Inc. |
Fairbairn, James Neville
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-21,294 vol |
21,294 | |
Filed 2023-12-14 22:52 Tx date 2023-06-29 |
$XRTX
XORTX Therapeutics Inc. |
Fairbairn, James Neville
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
42,588 | ||
Filed 2023-12-14 22:48 Tx date 2023-06-29 |
$XRTX
XORTX Therapeutics Inc. |
Fairbairn, James Neville
5 - Senior Officer of Issuer
Holder: 1282803 Ontario Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
47,430 | ||
Filed 2023-12-14 22:48 Tx date 2023-06-29 |
$XRTX
XORTX Therapeutics Inc. |
Fairbairn, James Neville
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
15,084 | ||
Filed 2023-12-14 22:39 Tx date 2023-11-10 |
$XRTX
XORTX Therapeutics Inc. |
Pratt, Raymond
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-26,667 vol |
6,666 | |
Filed 2023-12-14 22:38 Tx date 2023-11-10 |
$XRTX
XORTX Therapeutics Inc. |
Pratt, Raymond
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-26,667 vol |
33,333 | |
Filed 2023-12-14 22:34 Tx date 2023-11-10 |
$XRTX
XORTX Therapeutics Inc. |
Haworth, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-17,778 vol |
5,699 | |
Filed 2023-12-14 22:34 Tx date 2023-11-10 |
$XRTX
XORTX Therapeutics Inc. |
Haworth, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-8,889 vol |
23,477 | |
Filed 2023-12-14 22:32 Tx date 2023-11-10 |
$XRTX
XORTX Therapeutics Inc. |
Haworth, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-18,928 vol |
32,366 | |
Filed 2023-12-14 22:28 Tx date 2023-11-10 |
$XRTX
XORTX Therapeutics Inc. |
Farley, William James
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-26,667 vol |
7,221 | |
Filed 2023-12-14 22:27 Tx date 2023-11-10 |
$XRTX
XORTX Therapeutics Inc. |
Farley, William James
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-12,184 vol |
33,888 | |
Filed 2023-12-14 22:26 Tx date 2023-11-10 |
$XRTX
XORTX Therapeutics Inc. |
Farley, William James
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-18,928 vol |
46,072 | |
Filed 2023-12-14 21:24 Tx date 2023-11-10 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-56,883 vol |
7,110 | |
Filed 2023-12-14 21:23 Tx date 2023-03-19 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-12,776 vol |
77,224 | |
Filed 2023-12-14 21:20 Tx date 2023-11-10 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-26,667 vol |
8,579 | |
Filed 2023-12-14 21:19 Tx date 2023-11-10 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-19,264 vol |
35,246 | |
Filed 2023-12-14 21:18 Tx date 2023-11-10 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-22,714 vol |
54,510 | |
Filed 2023-12-14 17:57 Tx date 2023-11-10 |
$XRTX
XORTX Therapeutics Inc. |
May, Charlotte Mary-Anne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-4,445 vol |
26,438 | |
Filed 2023-12-14 17:56 Tx date 2023-11-10 |
$XRTX
XORTX Therapeutics Inc. |
May, Charlotte Mary-Anne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-18,928 vol |
30,883 | |
Filed 2023-12-14 17:21 Tx date 2023-11-10 |
$XRTX
XORTX Therapeutics Inc. |
May, Charlotte Mary-Anne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-13,334 vol |
13,104 | |
Filed 2023-12-14 17:12 Tx date 2023-11-10 |
$XRTX
XORTX Therapeutics Inc. |
May, Charlotte Mary-Anne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-4,445 vol |
||
Filed 2023-12-14 17:11 Tx date 2023-11-10 |
$XRTX
XORTX Therapeutics Inc. |
May, Charlotte Mary-Anne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-18,928 vol |
||
Filed 2023-12-14 16:47 Tx date 2023-11-10 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-84,287 vol |
17,489 | |
Filed 2023-12-14 16:46 Tx date 2023-11-10 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-17,778 vol |
101,776 | |
Filed 2023-12-14 16:44 Tx date 2023-11-10 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-37,857 vol |
119,554 | |
Filed 2023-12-14 15:26 Tx date 2023-11-10 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-415,660 vol |
51,957 | |
Filed 2023-12-13 15:58 Tx date 2023-12-13 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,589
+3,000 vol $2.53 each |
473,617 | |
Filed 2023-12-01 11:10 Tx date 2023-12-01 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,502
+2,600 vol $3.27 each |
470,617 | |
Filed 2023-12-01 11:07 Tx date 2023-12-01 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,306
+400 vol $3.27 each |
468,017 | |
Filed 2023-05-17 08:43 Tx date 2023-03-19 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-42,589 vol |
157,411 | |
Filed 2023-04-14 11:33 Tx date 2023-04-13 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,410
+1,500 vol $0.94 each |
467,617 | |
Filed 2023-04-10 12:31 Tx date 2023-03-31 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,320
+2,000 vol $0.66 each |
466,117 | |
Filed 2023-04-10 12:30 Tx date 2023-03-31 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,164
+1,800 vol $0.65 each |
464,117 | |
Filed 2023-03-27 15:49 Tx date 2023-03-27 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,320
+2,000 vol $0.66 each |
462,317 | |
Filed 2023-03-27 15:48 Tx date 2023-03-27 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,164
+1,800 vol $0.65 each |
460,317 | |
Filed 2023-03-24 12:46 Tx date 2023-03-22 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,267
+1,800 vol $0.70 each |
458,517 | |
Filed 2023-03-24 12:44 Tx date 2023-03-22 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,278
+1,800 vol $0.71 each |
456,717 | |
Filed 2023-03-24 12:44 Tx date 2023-03-22 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,775
+2,500 vol $0.71 each |
454,917 | |
Filed 2023-02-10 19:22 Tx date 2023-02-10 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$840.00
+1,000 vol $0.84 each |
452,417 | |
Filed 2023-02-03 13:00 Tx date 2023-02-02 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$860.00
+1,000 vol $0.86 each |
451,417 | |
Filed 2023-02-03 12:59 Tx date 2023-02-02 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$860.00
+1,000 vol $0.86 each |
450,417 | |
Filed 2023-02-03 12:59 Tx date 2023-02-02 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$870.00
+1,000 vol $0.87 each |
449,417 | |
Filed 2022-11-29 23:12 Tx date 2022-11-25 |
$XRTX
XORTX Therapeutics Inc. |
May, Charlotte Mary-Anne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
49,811 | |
Filed 2022-11-29 23:08 Tx date 2022-11-25 |
$XRTX
XORTX Therapeutics Inc. |
Haworth, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
51,294 | |
Filed 2022-11-29 23:04 Tx date 2022-11-25 |
$XRTX
XORTX Therapeutics Inc. |
Keshri, Amar Deep
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
51,294 | |
Filed 2022-11-25 23:23 Tx date 2022-11-11 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,920
+1,500 vol $1.28 each |
448,417 | |
Filed 2022-11-25 23:22 Tx date 2022-11-11 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$126.00
+100 vol $1.26 each |
446,917 | |
Filed 2022-11-25 23:22 Tx date 2022-11-11 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$375.00
+300 vol $1.25 each |
446,817 | |
Filed 2022-11-25 23:21 Tx date 2022-11-11 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,364
+1,100 vol $1.24 each |
446,517 | |
Filed 2022-11-25 23:20 Tx date 2022-11-11 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,690
+3,000 vol $1.23 each |
445,417 | |
Filed 2022-11-25 23:19 Tx date 2022-11-11 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,220
+1,000 vol $1.22 each |
442,417 | |
Filed 2022-11-25 23:18 Tx date 2022-11-11 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$600.00
+500 vol $1.20 each |
441,417 | |
Filed 2022-11-25 23:14 Tx date 2022-11-11 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,570
+3,000 vol $1.19 each |
440,917 | |
Filed 2022-10-21 23:51 Tx date 2022-10-19 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$665.00
+500 vol $1.33 each |
437,917 | |
Filed 2022-10-21 23:50 Tx date 2022-10-19 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,244
+1,700 vol $1.32 each |
437,417 | |
Filed 2022-10-21 23:49 Tx date 2022-10-19 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$393.00
+300 vol $1.31 each |
435,717 | |
Filed 2022-10-21 23:49 Tx date 2022-10-17 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,360
+2,000 vol $1.18 each |
435,417 | |
Filed 2022-10-21 23:48 Tx date 2022-10-17 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$600.00
+500 vol $1.20 each |
433,417 | |
Filed 2022-06-24 16:46 Tx date 2022-06-24 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,629
+1,000 vol $1.63 each |
432,917 | |
Filed 2022-06-24 16:46 Tx date 2022-06-22 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,600
+1,000 vol $1.60 each |
431,917 | |
Filed 2022-06-23 13:00 Tx date 2022-06-06 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
||
Filed 2022-06-09 22:42 Tx date 2022-06-06 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
||
Filed 2022-06-10 14:12 Tx date 2022-06-03 |
$XRTX
XORTX Therapeutics Inc. |
Giovinazzo, Anthony J.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$240,000
+150,000 vol $1.60 each |
150,000 | |
Filed 2022-06-10 14:09 Tx date 2022-06-03 |
$XRTX
XORTX Therapeutics Inc. |
Giovinazzo, Anthony J.
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-06-09 22:59 Tx date 2022-06-06 |
$XRTX
XORTX Therapeutics Inc. |
Davidoff, Allen Warren
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+94,822 vol |
200,000 | |
Filed 2022-06-09 22:57 Tx date 2022-06-06 |
$XRTX
XORTX Therapeutics Inc. |
Le Saux, Jacqueline Henriette Raymonde
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
65,000 | |
Filed 2022-06-09 22:54 Tx date 2022-06-06 |
$XRTX
XORTX Therapeutics Inc. |
Farley, William James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
65,000 | |
Filed 2022-06-09 22:52 Tx date 2022-06-06 |
$XRTX
XORTX Therapeutics Inc. |
Pratt, Raymond
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
60,000 | |
Filed 2022-06-09 22:42 Tx date 2022-06-06 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
120,000 | |
Filed 2022-06-08 18:24 Tx date 2022-06-06 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$48,000
+30,000 vol $1.60 each |
90,000 | |
Filed 2022-06-08 17:57 Tx date 2021-09-24 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-686,291 vol |
63,993 | |
Filed 2021-10-06 10:52 Tx date 2021-09-24 |
$XRTX
XORTX Therapeutics Inc. |
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-686,376 vol |
||
Filed 2022-06-06 11:16 Tx date 2022-06-06 |
$XRTX
XORTX Therapeutics Inc. |
Klassen, Ian McCulloch
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$48,000
+30,000 vol $1.60 each |
80,000 |